Market openNon-fractional

Ocular Therapeutix/OCUL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Ocular Therapeutix

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ticker

OCUL

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Bedford, United States

Employees

267

OCUL Metrics

BasicAdvanced
$1B
Market cap
-
P/E ratio
-$1.30
EPS
1.46
Beta
-
Dividend rate
$1B
1.46
21.394
20.966
17.859
18.237
-6.71%
-17.12%
-55.19%
10.451
2.53
2.53
-7.18
15.79%
8.70%
39.31%
-17.59%

What the Analysts think about OCUL

Analyst Ratings

Majority rating from 8 analysts.
Buy

OCUL Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-440.81% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$15M
-0.68%
Net income
-$65M
121.92%
Profit margin
-440.81%
123.43%

OCUL Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 155.97%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.26
-$0.01
-$0.35
-$0.49
-
Expected
-$0.30
-$0.29
-$0.30
-$0.19
-$0.22
Surprise
-13.91%
-96.52%
15.13%
155.97%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ocular Therapeutix stock?

Ocular Therapeutix (OCUL) has a market cap of $1B as of July 05, 2024.

What is the P/E ratio for Ocular Therapeutix stock?

The price to earnings (P/E) ratio for Ocular Therapeutix (OCUL) stock is 0 as of July 05, 2024.

Does Ocular Therapeutix stock pay dividends?

No, Ocular Therapeutix (OCUL) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Ocular Therapeutix dividend payment date?

Ocular Therapeutix (OCUL) stock does not pay dividends to its shareholders.

What is the beta indicator for Ocular Therapeutix?

Ocular Therapeutix (OCUL) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Ocular Therapeutix stock

Buy or sell Ocular Therapeutix stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing